GH Research PLC (GHRS) Deep Dive Video

Name: GH Research PLC (GHRS) Deep Dive Video | Flash
Uploaded: 2026-03-07T22:58:07.468
Description: GH Research is betting mebufotenin’s 11-minute psychedelic session can unlock blockbuster TRD outcomes by turning interventional psychiatry into a high-throughput, clinic-friendly model—if Phase 3 and the device pathway hold up.

Summary

GH Research is betting mebufotenin’s 11-minute psychedelic session can unlock blockbuster TRD outcomes by turning interventional psychiatry into a high-throughput, clinic-friendly model—if Phase 3 and the device pathway hold up.

View GHRS stock page · Read the GHRS research report

Loading the video player…